PremiumThe FlyHarvard Bioscience downgraded to Sector Weight from Overweight at KeyBanc Harvard Bioscience price target lowered to $4.50 from $5.50 at Benchmark Harvard Bioscience Reports 2024 Financial Results PremiumThe FlyHarvard Bioscience files $100M mixed securities shelf Harvard Bioscience Reveals Q3 2024 Financial Results Harvard Bioscience reports Q3 EPS (2c), consensus 3c PremiumThe FlyHarvard Bioscience sees FY24 revenue $97M-$102M Harvard Bioscience reports Q2 adjusted EPS 0c vs. 4c last year Harvard Bioscience (HBIO) Q2 Earnings Cheat Sheet 
